Back to basics in septic shock

This publication has 18 references indexed in Scilit:

• ACCM/PALS haemodynamic support guidelines for paediatric septic shock: an outcomes comparison with and without monitoring central venous oxygen saturation
  Intensive Care Medicine, 2008
• The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock*
  Critical Care Medicine, 2007
• Mechanotransduction and endothelial cell homeostasis: the wisdom of the cell
  American Journal of Physiology-Heart and Circulatory Physiology, 2007
• Severe secondary deficiency of von Willebrand factor–cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure
  Blood, 2006
• Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock*
  Critical Care Medicine, 2002
• New strategies for clinical trials in patients with sepsis and septic shock
  Critical Care Medicine, 2001
• Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial
  The Lancet, 2000
• Confirmatory interleukin-1 receptor antagonist trial in severe sepsis
  Critical Care Medicine, 1997
• Sepsis and controlled clinical trials
  Critical Care Medicine, 1995
• A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic Shock
  New England Journal of Medicine, 1987